Glenmark Pharmaceuticals Ltd has said that the GBR 500 deal signed by the company in May has received the second and final upfront payment of $25 million. With this payment, Glenmark has received the entire upfront payment of $50 million from Sanofi pertaining to the GBR - 500 deal.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.